Test drug CB03-154 10mg group

DRUG2 trials

Sponsors

Shanghai Zhimeng Biopharma, Inc.

Conditions

ALS (Amyotrophic Lateral Sclerosis)Focal Epilepsy

Phase 2

A Study to Evaluate the Safety, Tolerability, and Efficacy of CB03-154 in Adult Patients With Focal Epilepsy

Not yet recruitingNCT06612775

Shanghai Zhimeng Biopharma, Inc.Focal Epilepsy

Start: 2024-09-30End: 2026-09-30Target: 180Updated: 2024-09-25

A Study to Evaluate the Efficacy and Safety of Different Doses of CB03-154 in Adult Patients With Amyotrophic Lateral Sclerosis (ALS)

Not yet recruitingNCT07082192

Shanghai Zhimeng Biopharma, Inc.ALS (Amyotrophic Lateral Sclerosis)

Start: 2025-09-29End: 2027-10-31Target: 240Updated: 2025-07-24